scholarly article | Q13442814 |
P50 | author | Eric Youngstrom | Q27734333 |
Christoph Correll | Q56954221 | ||
Manon Hillegers | Q57884344 | ||
Cristian Zeni | Q58870981 | ||
David J Miklowitz | Q60474774 | ||
Boris Birmaher | Q63214888 | ||
Anna Van Meter | Q86153174 | ||
Benjamin I Goldstein | Q88048305 | ||
Robert L Findling | Q90314248 | ||
Melissa P DelBello | Q91939875 | ||
Robert A Kowatch | Q105682862 | ||
Gabrielle A. Carlson | Q109936328 | ||
Kiki D Chang | Q114270260 | ||
Janet Wozniak | Q114735122 | ||
Guillermo Perez Algorta | Q42852533 | ||
Mary Fristad | Q45882355 | ||
P2093 | author name string | Hyo-Won Kim | |
Fabiano G Nery | |||
P2860 | cites work | The functional neuroanatomy of bipolar disorder: a consensus model | Q22242603 |
The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study | Q22242740 | ||
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder | Q22242775 | ||
Evidence-based psychosocial treatments for child and adolescent bipolar spectrum disorders | Q22242988 | ||
Cyclothymic disorder: A critical review | Q22252261 | ||
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder | Q24655630 | ||
Pharmacotherapy of bipolar disorder in children and adolescents: an update | Q27027052 | ||
A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research | Q27027438 | ||
Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A) | Q28111792 | ||
National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments | Q28236815 | ||
Meta-analysis of epidemiologic studies of pediatric bipolar disorder | Q28240676 | ||
National trends in the outpatient diagnosis and treatment of bipolar disorder in youth | Q28244462 | ||
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder | Q28270795 | ||
Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004 | Q28288705 | ||
Treatment of bipolar disorder | Q28290437 | ||
How to understand divergent views on bipolar disorder in youth | Q28305112 | ||
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 | ||
A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: a randomized clinical trial | Q30370127 | ||
Clinical course of children with a depressive spectrum disorder and transient manic symptoms | Q34076546 | ||
Treatment development and feasibility study of family-focused treatment for adolescents with bipolar disorder and comorbid substance use disorders | Q34081359 | ||
Discriminative validity of parent report of hypomanic and depressive symptoms on the General Behavior Inventory | Q34082703 | ||
Alterations of regional homogeneity in pediatric bipolar depression: a resting-state fMRI study | Q34108908 | ||
Irritability without elation in a large bipolar youth sample: frequency and clinical description | Q34109233 | ||
Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials | Q34110848 | ||
Assessment of dysregulated children using the Child Behavior Checklist: A receiver operating characteristic curve analysis | Q34116144 | ||
Child Mania Rating Scale-Parent Version: a valid measure of symptom change due to pharmacotherapy | Q34139293 | ||
Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity | Q34183887 | ||
Evidence-Based Strategies Improve Assessment of Pediatric Bipolar Disorder by Community Practitioners | Q34188388 | ||
Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder | Q34239188 | ||
Neuroprogression in bipolar disorder | Q34282760 | ||
Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode | Q34294725 | ||
A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents | Q34300196 | ||
Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder. | Q30584521 | ||
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants | Q30991875 | ||
Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder | Q31969376 | ||
Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients | Q33226446 | ||
Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children | Q33405639 | ||
Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation | Q33411020 | ||
Correlation between amygdala volume and age in bipolar disorder - a systematic review and meta-analysis of structural MRI studies | Q33540436 | ||
Are there developmentally limited forms of bipolar disorder? | Q33565044 | ||
Subthreshold conditions as precursors for full syndrome disorders: a 15-year longitudinal study of multiple diagnostic classes | Q33583489 | ||
Fronto-temporal spontaneous resting state functional connectivity in pediatric bipolar disorder | Q33672508 | ||
Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study | Q33686046 | ||
Altered neural function in pediatric bipolar disorder during reversal learning | Q33735207 | ||
Controversies concerning the diagnosis and treatment of bipolar disorder in children | Q33758856 | ||
Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: a 2-year randomized trial | Q33850231 | ||
Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex | Q33874713 | ||
Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerability | Q33899006 | ||
Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. | Q33943502 | ||
Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial | Q33954717 | ||
Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative | Q34026000 | ||
Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial | Q34063590 | ||
Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy | Q36573680 | ||
Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition | Q36635732 | ||
Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study | Q36635758 | ||
A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents | Q36635790 | ||
Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis | Q36693361 | ||
Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorder | Q36706242 | ||
Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample | Q36707991 | ||
Disruptive Mood Dysregulation Disorder and Bipolar Disorder Not Otherwise Specified: Fraternal or Identical Twins? | Q36707997 | ||
Microstructural abnormalities of white matter differentiate pediatric and adult-onset bipolar disorder | Q36730834 | ||
Pilot Effectiveness Evaluation of Community-Based Multi-Family Psychoeducational Psychotherapy for Childhood Mood Disorders | Q36761065 | ||
Age associations with neural processing of reward anticipation in adolescents with bipolar disorders | Q36799267 | ||
Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials | Q36827082 | ||
Inflammatory markers among adolescents and young adults with bipolar spectrum disorders | Q36977336 | ||
An inexpensive family index of risk for mood issues improves identification of pediatric bipolar disorder | Q37118424 | ||
Generalizability of evidence-based assessment recommendations for pediatric bipolar disorder | Q37118438 | ||
Distinct relationships between social aptitude and dimensions of manic-like symptoms in youth | Q37139315 | ||
Comparison of aripiprazole and other atypical antipsychotics for pediatric bipolar disorder: a retrospective chart review of efficacy and tolerability | Q37155306 | ||
Diffusion tensor imaging study of white matter fiber tracts in pediatric bipolar disorder and attention-deficit/hyperactivity disorder | Q37180175 | ||
Predictors and moderators in the randomized trial of multifamily psychoeducational psychotherapy for childhood mood disorders | Q37230997 | ||
Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial | Q37246368 | ||
Effects of acute aerobic exercise on neural correlates of attention and inhibition in adolescents with bipolar disorder. | Q37349876 | ||
Lower orbital frontal white matter integrity in adolescents with bipolar I disorder | Q37354271 | ||
A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder | Q37358314 | ||
Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome | Q37362220 | ||
The Child Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in diagnosing pediatric bipolar disorder | Q37366141 | ||
Neurocognitive function in pediatric bipolar disorder: 3-year follow-up shows cognitive development lagging behind healthy youths | Q37412372 | ||
Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study | Q37453279 | ||
Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood | Q37502206 | ||
Factors influencing service utilization and mood symptom severity in children with mood disorders: effects of multifamily psychoeducation groups (MFPGs). | Q37503109 | ||
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors | Q37799094 | ||
Antidepressants and psychostimulants in pediatric populations: is there an association with mania? | Q37892521 | ||
Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis | Q37904401 | ||
Pharmacologic treatment of bipolar disorder in children and adolescents. | Q38049868 | ||
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force | Q38081648 | ||
Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis | Q38114586 | ||
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder | Q46874086 | ||
Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task | Q46887220 | ||
Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial | Q47298230 | ||
Genetic Risk Score Analysis in Early-Onset Bipolar Disorder. | Q47586738 | ||
Ten-year updated meta-analysis of the clinical characteristics of pediatric mania and hypomania | Q47598605 | ||
Characterizing exercise-induced feelings after one bout of exercise among adolescents with and without bipolar disorder | Q47622485 | ||
Correlations between amygdala volumes and serum levels of BDNF and NGF as a neurobiological markerin adolescents with bipolar disorder | Q47700088 | ||
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study | Q47902776 | ||
Controlled Study of Obesity Among Adolescents with Bipolar Disorder. | Q47913901 | ||
Negative expressed emotion best discriminates families with bipolar disorder children | Q47935567 | ||
Elevated triglycerides are associated with decreased executive function among adolescents with bipolar disorder | Q47997334 | ||
The Val66Met polymorphism at the BDNF gene does not influence Wisconsin Card Sorting Test results in children and adolescents with bipolar disorder | Q48091292 | ||
Antidepressant-emergent mood switch in Korean adolescents with mood disorder | Q48178181 | ||
Decreased right hippocampal volumes and neuroprogression markers in adolescents with bipolar disorder | Q48201797 | ||
Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community. | Q48225549 | ||
Diagnostic validity and reliability of a Korean version of the Parent and Adolescent General Behavior Inventories | Q48267177 | ||
Neural circuitry engaged during unsuccessful motor inhibition in pediatric bipolar disorder | Q48319766 | ||
The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder. | Q48438816 | ||
Preserved white matter in unmedicated pediatric bipolar disorder | Q48662634 | ||
Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response | Q49028509 | ||
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. | Q50707428 | ||
The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. | Q50734416 | ||
Expressed emotion moderates the effects of family-focused treatment for bipolar adolescents. | Q50744924 | ||
Psychopathology associated with suicidal ideation and attempts among children and adolescents. | Q50866812 | ||
Prevalence of DSM-III-R and ICD-10 psychiatric disorders in a Spanish population of 18-year-olds. | Q50927314 | ||
The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. | Q50961538 | ||
Bipolar disorder among adolescents and young adults: results from an epidemiological sample. | Q51854290 | ||
Acceptance of structured diagnostic interviews for mental disorders in clinical practice and research settings. | Q51865283 | ||
Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. | Q51907586 | ||
Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. | Q51915336 | ||
Long-term effectiveness and cost of a systematic care program for bipolar disorder. | Q51918257 | ||
Open-label lithium for the treatment of adolescents with bipolar depression. | Q51920328 | ||
The National Center on Indigenous Hawaiian Behavioral Health study of prevalence of psychiatric disorders in native Hawaiian adolescents. | Q51923659 | ||
Five-year prospective outcome of psychopathology in the adolescent offspring of bipolar parents. | Q51927892 | ||
Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. | Q51947781 | ||
Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. | Q52017239 | ||
A prospective study of bipolar disorder in children and adolescents from India. | Q52180780 | ||
Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. | Q52275733 | ||
Age at onset in bipolar I affective disorder in the USA and Europe | Q57698004 | ||
Linkage Disequilibrium of the Brain-Derived Neurotrophic FactorVal66MetPolymorphism in Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype | Q57774392 | ||
Incidence of childhood-onset bipolar illness in the USA and Europe | Q60646349 | ||
Preliminary studies of the reliability and validity of the children's depression rating scale | Q71328354 | ||
Recovery and Relapse in Adolescents with Bipolar Affective Illness: A Five-Year Naturalistic, Prospective Follow-up | Q71868722 | ||
Slow and rapid onset of manic episodes: implications for underlying biology | Q72003304 | ||
Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder | Q73125620 | ||
One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype | Q73395171 | ||
Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder | Q73501985 | ||
Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations | Q73802956 | ||
Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity | Q77402748 | ||
Controlled study of switching from attention-deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: rate, risk, and predictors | Q79299919 | ||
Differentiating bipolar disorder in Turkish prepubertal children with attention-deficit hyperactivity disorder | Q80149574 | ||
Prepubertal mania: diagnostic differences between US and UK clinicians | Q81312130 | ||
Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study | Q82078137 | ||
An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression | Q82844580 | ||
What we can all learn from the Treatment of Early Age Mania (TEAM) trial | Q84859736 | ||
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study | Q86199031 | ||
Comparison of clinical characteristics of bipolar and depressive disorders in Korean clinical sample of youth: a retrospective chart review | Q38130458 | ||
Lamotrigine treatment of adolescents with unipolar and bipolar depression: a retrospective chart review | Q38210562 | ||
Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. | Q38378026 | ||
Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial | Q38382241 | ||
Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents | Q38405563 | ||
Cardiovascular and psychiatric characteristics associated with oxidative stress markers among adolescents with bipolar disorder | Q38413784 | ||
Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a ¹H magnetic resonance spectroscopy study. | Q38429448 | ||
Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients | Q38440295 | ||
Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association | Q38564070 | ||
Association of Lipid Peroxidation and Brain-Derived Neurotrophic Factor with Executive Function in Adolescent Bipolar Disorder | Q38783691 | ||
Impulsivity is associated with blood pressure and waist circumference among adolescents with bipolar disorder | Q38817981 | ||
The Bipolar Prodrome: Meta-Analysis of Symptom Prevalence Prior to Initial or Recurrent Mood Episodes | Q38848569 | ||
BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder | Q38864271 | ||
Evidence-Based Psychotherapies and Nutritional Interventions for Children With Bipolar Spectrum Disorders and Their Families | Q38939725 | ||
Significance of borderline personality-spectrum symptoms among adolescents with bipolar disorder | Q39127053 | ||
Irritability in child and adolescent psychopathology: An integrative review for ICD-11. | Q39133706 | ||
The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders | Q39437531 | ||
Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders | Q39594097 | ||
Variability among research diagnostic interview instruments in the application of DSM-IV-TR criteria for pediatric bipolar disorder | Q39613030 | ||
Youth mental health in a populous city of the developing world: results from the Mexican Adolescent Mental Health Survey | Q39864096 | ||
Prevalence of psychiatric disorders in a Brazilian birth cohort of 11-year-olds. | Q39881863 | ||
A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder | Q39961276 | ||
Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder | Q40040533 | ||
Correlates of Overweight and Obesity Among Adolescents With Bipolar Disorder in the National Comorbidity Survey-Adolescent Supplement (NCS-A). | Q40463611 | ||
Self- and other-directed aggression in child and adolescent psychiatric inpatients | Q40526107 | ||
Disruptive Mood Dysregulation Disorder: Where Did It Come from and Where Is It Going | Q40837035 | ||
Binge eating and emotional eating behaviors among adolescents and young adults with bipolar disorder. | Q40902650 | ||
Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder. | Q41325445 | ||
Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial | Q41345424 | ||
Mediators in the randomized trial of Child- and Family-Focused Cognitive-Behavioral Therapy for pediatric bipolar disorder | Q41633664 | ||
Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression | Q41731877 | ||
Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders | Q42633896 | ||
GAD1 single nucleotide polymorphism is in linkage disequilibrium with a child bipolar I disorder phenotype | Q42646074 | ||
Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination | Q43104439 | ||
Differential brain activation during response inhibition in bipolar and attention-deficit hyperactivity disorders | Q43540747 | ||
Clinical implications of DSM-IV subtyping of bipolar disorders in referred children and adolescents. | Q43632988 | ||
Examining the validity of cyclothymic disorder in a youth sample: replication and extension | Q43679103 | ||
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing | Q43697094 | ||
Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study | Q43868614 | ||
Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. | Q44048838 | ||
Bipolar disorder: the shift to overdiagnosis | Q34311476 | ||
Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder | Q34332307 | ||
Implementation of multi-family psychoeducational psychotherapy for childhood mood disorders in an outpatient community setting | Q34344440 | ||
Meta-analyses of developing brain function in high-risk and emerged bipolar disorder | Q34441637 | ||
10-year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden | Q34452545 | ||
Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder | Q34505551 | ||
Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates | Q34508095 | ||
Child mania rating scale: development, reliability, and validity | Q34511729 | ||
Prevalence and Correlates of Disruptive Mood Dysregulation Disorder Among Adolescents with Bipolar Disorder | Q34512375 | ||
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents | Q34568810 | ||
Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of Children | Q34624613 | ||
Altered regional homogeneity in pediatric bipolar disorder during manic state: a resting-state fMRI study | Q34634048 | ||
Changes in brain activation following psychotherapy for youth with mood dysregulation at familial risk for bipolar disorder | Q34646564 | ||
Accuracy of brief and full forms of the Child Mania Rating Scale | Q34755963 | ||
Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents | Q34775496 | ||
Predictors and moderators of agreement between clinical and research diagnoses for children and adolescents | Q34783443 | ||
The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder | Q34787700 | ||
Clinical course of children and adolescents with bipolar spectrum disorders | Q34814593 | ||
Youth meeting symptom and impairment criteria for mania-like episodes lasting less than four days: an epidemiological enquiry | Q34866613 | ||
Meta-analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews. | Q34999040 | ||
Interpersonal and social rhythm therapy for adolescents with bipolar disorder: treatment development and results from an open trial | Q35054290 | ||
Defining clinical phenotypes of juvenile mania | Q35075420 | ||
Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders | Q35077567 | ||
Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial | Q35200191 | ||
High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study | Q35242995 | ||
Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified | Q35257409 | ||
Progression of amygdala volumetric abnormalities in adolescents after their first manic episode | Q35275558 | ||
Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders | Q35496330 | ||
Correlation between Peripheral Levels of Brain-Derived Neurotrophic Factor and Hippocampal Volume in Children and Adolescents with Bipolar Disorder | Q35649671 | ||
Manic symptoms in youth: dimensions, latent classes, and associations with parental psychopathology | Q35771392 | ||
Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study. | Q35843375 | ||
Family-based association study of early growth response gene 3 with child bipolar I disorder | Q35949890 | ||
Developmental meta-analyses of the functional neural correlates of bipolar disorder | Q35984999 | ||
Intrinsic Amygdala Functional Connectivity in Youth With Bipolar I Disorder | Q35994602 | ||
A preliminary investigation of corpus callosum and anterior commissure aberrations in aggressive youth with bipolar disorders | Q35995091 | ||
Medical decision making: a selective review for child psychiatrists and psychologists | Q36171341 | ||
Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study | Q36188647 | ||
Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study | Q36210565 | ||
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders | Q36354301 | ||
Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents | Q36364796 | ||
A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder. | Q36405769 | ||
Reward processing in adolescents with bipolar I disorder | Q36488566 | ||
Cognitive remediation: potential novel brain-based treatment for bipolar disorder in children and adolescents | Q36490464 | ||
Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). | Q44127927 | ||
Phenomenology of children and adolescents with bipolar spectrum disorders | Q44270072 | ||
Decreased N-acetylaspartate in children with familial bipolar disorder | Q44466569 | ||
Combined analyses of gray matter voxel-based morphometry and white matter tract-based spatial statistics in pediatric bipolar mania | Q44534562 | ||
Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents | Q44538148 | ||
Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders | Q44772441 | ||
Psychopathology in children aged 10-17 of bipolar parents: psychopathology rate and correlates of the severity of the psychopathology | Q44820453 | ||
Increased parental history of bipolar disorder in the United States: association with early age of onset | Q44962068 | ||
White matter abnormalities in children with and at risk for bipolar disorder | Q44975394 | ||
Structural brain and neuropsychometric changes associated with pediatric bipolar disorder with psychosis | Q45046746 | ||
A prospective 4-5 year follow-up of juvenile onset bipolar disorder | Q45070764 | ||
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. | Q45206307 | ||
Categorical and dimensional psychopathology in Dutch and US offspring of parents with bipolar disorder: A preliminary cross-national comparison. | Q45728809 | ||
Age differences in the phenomenology of pediatric bipolar disorder. | Q45912234 | ||
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents | Q46072648 | ||
Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder | Q46115006 | ||
Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. | Q46155653 | ||
1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients | Q46429555 | ||
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder | Q46448298 | ||
A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder | Q46503060 | ||
Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium | Q46624948 | ||
Challenging times: prevalence of psychiatric disorders and suicidal behaviours in Irish adolescents | Q46733878 | ||
Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study | Q46808074 | ||
P433 | issue | 7 | |
P921 | main subject | bipolar disorder | Q131755 |
P304 | page(s) | 524-543 | |
P577 | publication date | 2017-09-25 | |
P1433 | published in | Bipolar Disorders | Q15716681 |
P1476 | title | The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research | |
P478 | volume | 19 |
Q92258081 | Adaptation of Multi-Family Psychoeducational Psychotherapy (MF-PEP) for Adolescents with Mood Disorders: Preliminary Findings |
Q52656684 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. |
Q64280151 | Developmental Delay, Hyperactivity and Mania: A Perfect Blend of Confusion in a Preschool Child |
Q91834532 | Evidence-Based Assessment from Simple Clinical Judgments to Statistical Learning: Evaluating a Range of Options Using Pediatric Bipolar Disorder as a Diagnostic Challenge |
Q92166698 | Excitability and irritability in preschoolers predicts later psychopathology: The importance of positive and negative emotion dysregulation |
Q98288971 | Functional Impairment and Clinical Correlates in Adolescents with Bipolar Disorder Compared to Healthy Controls. A Case-control Study |
Q89545373 | Helping Families to Understand and Cope With Psychiatric Disorders in Childhood-Beyond Basic Facts |
Q95840818 | Lithium Treatment Over the Lifespan in Bipolar Disorders |
Q92843449 | Maintenance Pharmacological Treatment of Juvenile Bipolar Disorder: Review and Meta-Analyses |
Q53406441 | Predicting enrollment in two randomized controlled trials of nonpharmacologic interventions for youth with primary mood disorders. |
Q90432698 | Psychotic and affective symptoms of early-onset bipolar disorder: an observational study of patients in first manic episode |
Q93337518 | The morbidity of subthreshold pediatric bipolar disorder: A systematic literature review and meta-analysis |
Q55032553 | Treatment-Emergent Mania in a Prepubertal Boy. |
Search more.